Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/222841
Title: | Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy |
Author: | Schiava, Marianela Parkhurst, Yolande Henderson, Matthew Polvikoski, Tuomo Valtcheva, Manouela V. Nishino, Ichizo Inoue, Michio Nishimori, Yukako Saito, Yoshihiko Stojkovic, Tanya Villar Quiles, Rocio N. Beatriz Romero, Norma Evangelista, Teresinha Malfatti, Edoardo Souvannanorath, Sarah Pegoraro, Elena Riguzzi, Pietro Monforte, Mauro Bortolani, Sara Torchia, Eleonora Sabatelli, Mario Tasca, Giorgio Straub, Volker Marini Bettolo, Chiara Guglieri, Michela Cetin, Hakan Gelpi, Ellen Klotz, Sigrid De Bleecker, Jan L. Alonso Jiménez, Alicia Baets, Jonathan De Ridder, Willem De Jonghe, Peter Claeys, Kristl G. Thal, Dietmar Rudolf Bevilacqua, Jorge A. Luo, Sushan Zhu, Wenhua Lin, Jie Papadimas, George Papadopoulos, Constantinos Zamba-Papanicolaou, Eleni Xirou, Sophia Pal, Endre Rodolico, Carmelo Kostera-Pruszczyk, Anna Kierdaszuk, Biruta Kaminska, Anna Muelas, Nuria Vilchez, Juan Jesús Domínguez González, Cristina Hernández Lain, Aurelio Alonso Pérez, Jorge Nedkova-Hristova, Velina Aledo, Carlos Oldfors, Anders Badrising, Umesh A. Kushlaf, Hani Lloyd, Thomas E. Ikenaga, Chiseko Alfano, Lindsay N. Quinn, Colin C. Walk, David Vorgerd, Matthias Weihl, Conrad Olivé i Plana, Montserrat Díaz Manera, Jordi VCP International Study Group |
Keywords: | Malalties neuromusculars Paraproteïnèmia Neuromuscular diseases Paraproteinemia |
Issue Date: | 16-Jul-2025 |
Publisher: | Ovid Technologies (Wolters Kluwer Health) |
Abstract: | Background and Objectives Valosin Containing Protein-associated multisystem proteinopathy (VCP-MSP) is a progressive, autosomal dominant disorder caused by pathogenic variants in the VCP gene, resulting in a heterogeneous clinical presentation. Muscle biopsy findings are characteristic but not pathognomonic. This study aimed to comprehensively analyse VCP-related myopathology and explore correlations with clinical phenotypes, genetic variants, and disease progression. Methods Muscle biopsy images and data were collected retrospectively from adults (>= 18 years) with pathogenic or likely pathogenic VCP variants enrolled in the VCP Multicentre International Study. Biopsy data were standardized using the Common Data Elements for Muscle Biopsy Reporting. Variations in biopsy findings were analysed by biopsy site, time from disease onset, the four most common VCP variants, and clinical phenotypes. Result A total of 112 muscle biopsies were included. Most individuals were male (66.0%). The mean age at biopsy was 53.3 years (SD 10.0), with a mean disease duration of 6.5 years (SD 4.5). The most frequent VCP variant was c.464G>A (p.Arg155His) (18.8%). The top clinical phenotypes were isolated myopathy (37.5%), myopathy with Paget disease of bone (17.9%), and myopathy with motor neuron involvement (13.4%). The vastus lateralis was the most common biopsy site (34.8%), and 91% were open biopsies. Histopathologic findings included atrophic fibres (87.5%), rimmed vacuoles (72.3%), endomysial fibrosis (58.0%), and protein aggregates (51.8%), primarily p62 (60.3%) and VCP (36.2%). Degeneration niches with fibrofatty replacement and atrophic fibres were seen in 33.3% of biopsies without frequency differences by clinical phenotypes. There were no differences in biopsy findings among the 4 most common VCP gene variants, except for the absence of degeneration niches in muscle biopsies of 12 patients with c.277C>T (p.Arg93Cys). MRI data from 30 patients showed fat pockets corresponding to these niches and STIR hyperintensity correlated with inflammatory infiltrates in 42.9%. Concordance between clinical phenotype, biopsy, and neurophysiology was observed in only 49.4% of cases, indicating significant heterogeneity. Discussion VCP-MSP muscle biopsies consistently show myopathic or mixed patterns with rimmed vacuoles and p62/VCP-positive inclusions, regardless of clinical phenotype, age, or progression. Some lack vacuoles, challenging diagnosis. Discrepancies between clinical, neurophysiology, and biopsy findings should prompt consideration of VCP-MSP to improve detection and management. |
Note: | Reproducció del document publicat a: https://doi.org/10.1212/NXG.0000000000200265 |
It is part of: | Neurology Genetics, 2025, vol. 11, num. 4 |
URI: | https://hdl.handle.net/2445/222841 |
Related resource: | https://doi.org/10.1212/NXG.0000000000200265 |
ISSN: | 2376-7839 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
schiava-et-al-2025-muscle-biopsy-findings-in-valosin-containing-protein-multisystem-proteinopathy.pdf | 952.07 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License